Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis

NCT01130844 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT01130844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01130844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Lead sponsor
Shire
Phase
Phase 1
Overall status
Completed
Start date
October 8, 2010
Completion date
June 27, 2013
Enrollment
52 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis